Cryoport Inc 's Comment on Competitors and Industry Peers
Our products and services are sold into a rapidly growing segment of the logistics
industry focused on the temperature sensitive packaging and shipping of biological
materials. Expenditures for “value added” packaging for frozen transport
have been increasing for the past several years and, due in part to continued
globalization, are expected to continue to increase even more in the future as
more domestic and international biotechnology firms introduce pharmaceutical products
that require continuous refrigeration at cryogenic temperatures. We believe this
will require a greater dependence on passively controlled temperature transport
systems (i.e., systems having no external power source). In addition, we expect
that industry standards and regulations will be introduced globally, requiring
more comprehensive tracking and validation of shipping temperatures.
We believe that growth in the following markets has resulted in the need for increased
reliability, efficiencies and greater flexibility in the temperature sensitive
segment of the logistics market:
· cell-based therapies
· gene and stem cell biotechnology
· cell lines
· vaccine production
· commercial drug product distribution
· clinical trials, including transport of tissue culture samples
· diagnostic specimens
· infectious sample materials
· inter/intra-laboratory diagnostic testing
· temperature-sensitive specimens
· biological samples, in general
· environmental sampling
· IVF
· animal husbandry
Many of the biological products in these above markets require transport in a
frozen state as well as the need for shipping containers which have the ability
to maintain a frozen, cryogenic environment (e.g., minus 150° Celsius) for
a period ranging from two to ten days (depending on the distance and mode of shipment).
These products include stem cells, semen, embryo, tissue, tissue cultures, cultures
of viruses and bacteria, enzymes, DNA materials, vaccines and certain pharmaceutical
products.
One of the integral parts of our solutions are our Cryoport Express® Shippers
that are based on a liquid nitrogen dry vapor technology. The following paragraphs
compare our shippers with dry ice and liquid nitrogen shipping methods. Our solutions
integrate the Cryoport Express® Shippers with our CryoportalTM logistics software
platform and our cold chain logistics know-how that are comprehensive and tailored
to client requirements.